NEW YORK (Reuters Health) – Compared with unfractionated heparin, bivalirudin used for anticoagulation in unselected patients undergoing percutaneous coronary intervention is associated with less bleeding after 1 month…
NEW YORK (Reuters Health) – The diagnostic accuracy of rotational coronary angiography is as good as that of conventional angiography, but it significantly reduces the amount of radiation…
NEW YORK (Reuters Health) – Determining the low-density lipoprotein particle (LDL-p) concentration in women with HIV doesn’t seem to be worthwhile, as doing so adds little information beyond…
NEW YORK (Reuters Health) – In recipients of drug-eluting coronary stents who undergo a major noncardiac surgical procedure some months later, the risk of adverse outcomes is less…
NEW YORK (Reuters Health) – Left ventricular thrombus is still quite a frequent finding in patients with an anterior wall MI who have been treated by percutaneous coronary…
NEW YORK (Reuters Health) – Patients with NYHA class I or II heart failure benefit from spironolactone therapy as well as those with class III or IV HF,…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…
NEW YORK (Reuters Health) – The concern about proton pump inhibitors (PPIs) possibly interfering with the efficacy of clopidogrel may be misdirected, according to a new report. It…
NEW YORK (Reuters Health) – Left atrial volume rather than diameter is more strongly associated with thromboembolic risk markers in patients with mitral stenosis, and should be used…
NEW YORK (Reuters Health) – The antiplatelet effect of clopidogrel is much reduced in patients undergoing therapeutic hypothermia after cardiac arrest, according to a Norwegian study published online…